Cantel Medical Corporation
CMD
CMD was delisted on the 1st of June, 2021.
286 hedge funds and large institutions have $3.35B invested in Cantel Medical Corporation in 2018 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 110 increasing their positions, 95 reducing their positions, and 49 closing their positions.
16% more repeat investments, than reductions
Existing positions increased: 110 | Existing positions reduced: 95
3% less capital invested
Capital invested by funds: $3.44B → $3.35B (-$92.1M)
2% less funds holding
Funds holding: 292 → 286 (-6)
10% less first-time investments, than exits
New positions opened: 44 | Existing positions closed: 49
24% less call options, than puts
Call options by funds: $4.7M | Put options by funds: $6.16M
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FAM
Fred Alger Management
New York
|
+$65.4M |
| 2 |
Los Angeles Capital Management
Los Angeles,
California
|
+$32M |
| 3 |
CCA
Conestoga Capital Advisors
Wayne,
Pennsylvania
|
+$28M |
| 4 |
Mackenzie Financial
Toronto Ontario,
Ontario, Canada
|
+$19.3M |
| 5 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$16.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OppenheimerFunds
New York
|
-$23M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$20.4M |
| 3 |
Westfield Capital Management
Boston,
Massachusetts
|
-$17.7M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$17.3M |
| 5 |
Wells Fargo
San Francisco,
California
|
-$10.4M |
CMD Hedge Fund Activity: Q3 2018 in Review
286 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Cantel Medical Corporation (CMD) for Q3 2018, worth a combined $3.35B — down 2.7% from $3.44B a quarter earlier.
Sellers outnumbered buyers: 49 funds closed out of CMD and 44 opened new positions — a net loss of 5 holders — while 95 trimmed existing stakes and 110 added.
The largest buyer was Fred Alger Management, adding an estimated $65.4M. The largest seller was OppenheimerFunds, cutting an estimated $23M.
- 286 institutional investors held Cantel Medical Corporation (CMD) as of Q3 2018, down from 292 in Q2 2018.
- Funds reported $3.35B of Cantel Medical Corporation stock for Q3 2018, down 2.7% quarter-over-quarter.
- 44 funds opened new Cantel Medical Corporation positions in Q3 2018 and 49 closed out, a net change of -5 holders.
- The largest Cantel Medical Corporation buyer in Q3 2018 was Fred Alger Management, an estimated $65.4M added.
- The largest Cantel Medical Corporation seller in Q3 2018 was OppenheimerFunds, an estimated $23M sold.
Based on aggregated 13F filings for Q3 2018.